Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights.
Authors:
- 28 July 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (28) , 9439-50
Abstract
Previous reports clearly demonstrated that Helicobacter pylori (H. pylori) infection, nonsteroidal anti-inflammatory drugs (NSAID) or low dose aspirin (ASA) use significantly and independently increased the risk for the development of peptic ulcer disease. Today, the presence of H. pylori infection associated with low dose ASA and/or NSAID use in the same patient is becoming more frequent and therefore the potential interaction between these factors and the consequences of it has important implications. Whether NSAID intake in the presence of H. pylori infection may further increase the risk of peptic ulcer carried by the presence of only one risk factor is still a matter of debate. Studies on the interaction between the two risk factors yielded conflicting data and no consensus has been reached in the last years. In addition, the interaction between H. pylori infection and low-dose ASA remains even more controversial. In real clinical practice, we can find different clinical scenarios involving these three factors associated with the presence of different gastrointestinal and cardiovascular risk factors. These huge variety of possible combinations greatly hinder the decision making process of physicians.Keywords
This publication has 82 references indexed in Scilit:
- Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: A double-blind trialGastroenterology, 2004
- Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trialThe Lancet, 2004
- Effect of Helicobacter pylori eradication on anti‐thrombotic dose aspirin‐induced gastroduodenal mucosal injuryJournal of Gastroenterology and Hepatology, 2004
- Genetic predisposition to acute gastrointestinal bleeding after NSAIDs useBritish Journal of Pharmacology, 2004
- Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
- Relative contribution of acetylated cyclooxygenase (COX)‐2 and 5‐lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirinThe FASEB Journal, 2003
- Changing Rates of Helicobacter pylori Testing and Treatment in Patients With Peptic Ulcer DiseaseAmerican Journal of Gastroenterology, 2002
- Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritisGastroenterology, 2002
- Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.Gut, 1987
- INGESTION OF CAMPYLOBACTER-PYLORIDIS CAUSES GASTRITIS AND RAISED FASTING GASTRIC PH1987